Dow Up 0.47% Nasdaq Up 0.50%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
51.34 Up 0.21(0.41%) 10:16AM EDT - Nasdaq Real Time Price
Prev Close:51.13
Open:51.42
Bid:51.77 x 400
Ask:51.97 x 100
1y Target Est:84.80
Beta:1.23
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:50.25 - 52.01
52wk Range:39.75 - 80.42
Volume:41,001
Avg Vol (3m):414,959
Market Cap:1.07B
P/E (ttm):88.06
EPS (ttm):0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LGND

Comparison

Symbol% ChgMkt Cap
LGNDUp 0.41%1.07B
LLYUp 0.86%71.25B
MRKUp 0.34%173.33B
RHHBYUp 1.19%256.92B

Key Statistics

Forward P/E (1 yr):21.39
P/S (ttm):19.56
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.55
Quarterly EPS Est (Sep-14) :0.32
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback